AAVnerGene Inc.
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
AAVnerGene Inc. is a biotechnology company that develops advanced gene therapy technologies and AAV vector platforms to improve manufacturing efficiency and tissue-targeted delivery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AAVnerGene Inc. Comparables
Compare AAVnerGene Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PackGene Biotech | 79% | |
| Capsigen | 77% | |
| Asimov | 77% | |
AAVnerGene Inc. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors grew 111% MoM, reaching 10.8K.
- Jun 1, 2025
Monthly visitors increased 38% MoM to 3.3K.
AAVnerGene Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AAVnerGene Inc.'s valuation, stock price, and market status.